Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
BVS · against 589 other Healthcare companies listed in US-listed
Ranked #39 of 590 · scores higher than 93% of peers
Bars: peers in each 10-point band of the valuation score25 peers with a valuation score of 80–89, including BVS · Click a bar to see the companies
Mainly thanks to its free cash flow yield, earnings yield and EBITDA yield, which are stronger than most Healthcare peers.
| Metric | BVS | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 577 reported | 7.3% | -4.4% | 94% | 30% | |
| EBITDA yieldHigher is better · 578 reported | 7.9% | -0.8% | 83% | 50% | |
| Free cash flow yieldHigher is better · 554 reported | 12.9% | -2.3% | 96% | 20% | |
| Book yieldHigher is better · 587 reported | 31.3% | 26.6% | 57% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 253M USD | 98 | 80 | |
| 2 | 2.2B USD | 97 | 97 | |
| 3 | 563M USD | 96 | 97 | |
| 3 | 408M USD | 96 | 81 | |
| 3 | 322M USD | 96 | 57 | |
| 34 | 1.4B USD | 86 | 65 | |
| 37 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
| 4.3B USD |
| 85 |
| 69 |
| 37 | 343M USD | 85 | 68 |
| 39 | 1.2B USD | 84 | 52 |
| 39 | 729M USD | 84 | 63 |
| 39 | 33.9B USD | 84 | 58 |
| 42 | 1.4B USD | 83 | 73 |
| 42 | 676M USD | 83 | 48 |
| 42 | 23.9B USD | 83 | 84 |